Search

everythinglearnresearchcommunity

for

Search:↓

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

Hair restoration surgery can be safely done without major bleeding in patients on antithrombotic therapy, and these drugs shouldn't be stopped before surgery.

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

A child with rickets and hair loss might have a rare type of rickets that doesn't improve much with usual vitamin D and calcium treatment.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.

Oral ulcers are common in SLE patients and often link to other symptoms.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

No cure exists for alopecia areata, and treatments are personalized.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Finasteride effectively treats male hair loss, improving growth and density.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Daily low-dose aspirin lowers minoxidil's effectiveness for hair loss treatment.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Zidovudine may cause hair loss in advanced-stage HIV patients.